Premier Educational Event for Forward Thinking, Outcome-Focused, Health-Centered Professionals
AGENDA
Diverse, interactive, and engaging sessions have been tailored to ensure maximal impact in a virtual setting. Join us live this October 3rd-4th and/or access on-demand sessions thereafter through Dec 31st, 2023.
Keynotes and Plenaries
Clinical Sessions
Lab Medicine Sessions
Executive Sessions
Management Sessions
Hot Topics
MUST SEE SESSIONS:
Michael Dowling, President and CEO, Northwell Health
MICHAEL DOWLING is one of healthcare’s most influential voices. As President and CEO of Northwell Health, he leads a clinical, academic and research enterprise of more than 84,000 employees and annual revenue of $16.5 billion. Michael has a track record of invaluable leadership enabling consistent expansion and prominence, while also helping to navigate trying times such as the COVID-19 pandemic. Receiving many honors over the years, Michael was recently recognized as the #1 Leader on Modern Healthcare’s 100 Most Influential Leaders in Healthcare for 2022.
Quint Studer, Co-Founder, Healthcare Plus Solutions Group, USA
QUINT STUDER is a visionary entrepreneur, transformative healthcare leader, giving philanthropist, and best-selling author. His newest book, The Calling: Why Healthcare Is So Special, is aimed at helping healthcare professionals keep their sense of passion and purpose high. Quint also serves on various healthcare boards and is a frequent speaker, workshop facilitator, and mentor to individuals and organizations. The tools and techniques Mr. Studer has created over the years are now staples in healthcare systems throughout the world. For more information on Mr. Studer please visit HealthcarePlusSG.com.
Vicki Briggs, LFACHE, Retired Healthcare CEO
VICKI BRIGGS is a lifetime Fellow of the American College of Healthcare Executives and former (retired) CEO at UT Health Tyler, Texas. Her vast healthcare experience spans over 35 years of C-Suite experience in hospital and healthcare system administration, both in the not-for-profit and for-profit healthcare sectors.
Christina Mack, Chief Scientific Officer, IQVIA Real World Solutions
David Weiss, Senior Vice President, Player Matters, National Basketball Association
DR. CHRISTINA MACK is an epidemiologist and Chief Scientific Officer at IQVIA Real World Solutions. Dr. Mack has extensive expertise using computer science engineering and epidemiology to utilize data for improving patient outcomes and population health. During the COVID-19 pandemic, Dr. Mack led a number of public health initiatives, beginning with the innovative National Basketball Association COVID-19 Bubble which provided a foundation for broad public health efforts.
DAVID WEISS is Senior Vice President of Player Matters for the NBA, serving as a key leader in player health and safety matters. During the COVID-19 pandemic in 2020, David, along with his team, strategically designed, innovated and implemented the NBA COVID-19 Bubble.
Craig Ivany, CHIEF PROVINCIAL DIAGNOSTICS OFFICER, Provincial Health Services Authority
Khosrow Shotorbani, PRESIDENT, EXECUTIVE DIRECTOR, PROJECT SANTA FE FOUNDATION, FOUNDER, CEO, LAB 2.0 STRATEGIC SERVICES
CRAIG IVANY is the Chief Provincial Diagnostics Officer for PROVINCIAL HEALTH SERVICES AUTHORITY in British Columbia, Canada and a laboratory services strategist with over 35 years of experience influencing healthcare. His depth of practice includes a legacy of leadership across Canada, including senior roles across the private and public sectors.
KHOSROW SHOTORBANI is the CEO and founder of Lab 2.0 Strategic Services, LLC and the visionary leader, President and Executive Director of the Project Santa Fe Foundation. Khosrow strives to help drive strategic changes within healthcare that will define future economic valuation and placement of diagnostic services and practice of laboratory medicine.
SPEAKERS
Join us and these representative top leaders from across the globe for this prestigious program on healthcare excellence. Don’t miss this chance to interact, learn from, and be part of these valued conversations.
Vicki Briggs
LFACHE, Retired Healthcare CEO
USA
Christina Caraballo
Vice President, Informatics
HIMSS, USA
Alex Carterson
Divisional Vice President, Medical
Abbott, USA
Rob Christenson
Professor of Pathology and Professor of Medical and Research Technology
University of Maryland School of Medicine, USA
Ian Cormack
Clinical Lead HIV Medicine
Croydon University Hospital, UK
Ted Donnelly
Vice President, Client Success
National Association for Healthcare Quality, USA
Michael Dowling
President and CEO
Northwell Health, USA
Paul Epner
Vice-Chair
Sepsis Alliance, USA
Shaun Francis
Chair and Chief Executive Officer
Medcan Healthcare Inc., Canada
David Grenache
Chief Scientific Officer
TriCore Reference Laboratories, USA
Shannon Haymond
Associate Professor of Pathology
Northwestern University Feinberg School of Medicine, USA
Craig Ivany
Chief Provincial Diagnostics Officer
Provincial Health Services Authority, Canada
Adeeba Kamarulzaman
Dean of the Faculty of Medicine and Professor of Medicine and Infectious Diseases
University of Malaya, Malaysia
Peter Kavsak
Professor, Pathology & Molecular Medicine
McMaster University, Canada
Federico Lega
Full Professor, Department of Biomedical Sciences for Health
University of Milan, Italy
Fawn Lopez
Publisher Emeritus
Modern Healthcare, USA
Christina Mack
Chief Scientific Officer
IQVIA Real World Solutions, USA
Rory McCrimmon
Dean of Medicine
University of Dundee, Scotland
Ketul J. Patel
Chief Executive Officer Virginia Mason Franciscan Health & Division President
Pacific Northwest, CommonSpirit Health, USA
Octavia Peck-Palmer
Division Director, Clinical Chemistry, Associate Professor of Pathology
University of Pittsburgh School of Medicine, USA
Emma Page
Diabetes Transformation Manager
Ipswich Hospital, East Suffolk and North Essex NHS Foundation Trust, England
Amy Perry
President and Chief Operating Officer
Banner Health, USA
Tricia Ravalico
Director, Scientific Leadership and Education, Core Diagnostics
Abbott, USA
Gerry Rayman
Consultant Diabetologist, Clinical Lead for Diabetes
Ipswich Hospital, East Suffolk and North Essex NHS Foundation Trust, England
Melissa Ryan
Scientific Marketing Manager, Global Marketing
Abbott, USA
Marion Saville
Executive Director
Australian Centre for the Prevention of Cervical Cancer, Australia
Khosrow Shotorbani
President, Executive Director
Project Santa Fe Foundation, USA
Founder, CEO
Lab 2.0 Strategic Services, USA
Quint Studer
Co-founder
Healthcare Plus Solutions Group, USA
John Sproule
Senior Policy Director
Institution of Health Economics, Canada
Colleen Strain
Manager, Scientific Leadership and Education, Core Diagnostics
Abbott, Canada
Annette Walker
President
City of Hope of Orange County, USA
David Weiss
Senior Vice President of Player Matters
National Basketball Association, USA
Richard Whitlock
Professor & Division Head
McMaster University, Canada
Yin Ling Woo
Professor of Obstetrics and Gynaecology, Consultant Gynaecological Oncologist
University of Malaya, University Malaya Medical Centre, Malaysia
Vahe Avayzian
Divisional Vice President, Global Marketing
Abbott, USA
PARTNERS
The 2023 Executive Leadership Exchange has been created in partnership with the UNIVANTS of Healthcare Excellence program, a globally renowned collaboration of eight leading healthcare organizations that span diverse facets of healthcare including healthcare quality, health economics, healthcare policy, c-suite executives, laboratory medicine, and the IVD industry.
EDUCATIONAL CREDITS
In partnership with AACC, the Executive Leadership Exchange is being planned in accordance with ACCENT® standards and policies.
LEARNING OBJECTIVES
At the end of this activity, participants should be able to:
- Recognize the essential pillars of successful, transformational care, including teamwork, innovative thinking and measures success, while also recognizing the pivotal role of laboratory medicine in achieving measurably better healthcare.
- Describe evolving capabilities of healthcare and healthcare professionals as strategic collaborators for enhanced health and business outcomes.
- Explain future opportunities and next steps for healthcare transformations within their own institutions.
ACCREDITATION STATEMENT: This activity is approved for 15.25 ACCENT® continuing education credits. Activity ID# 4243. This activity was planned in accordance with ACCENT® Standards and Policies.
To claim continuing education credit, please visit the evaluation link found here.
DISCLOSURES AND STATEMENT OF INDEPENDENCE
AACC is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments. All relevant financial relationships were mitigated. Disclosure information is provided in faculty profiles.
CONTENT VALIDITY
All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
SUCCESSFUL COMPLETION STATEMENT
Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@myadlm.org.
RELEASE DATE: October 3, 2023
EXPIRATION DATE: December 31, 2024
CONTACT US
"*" indicates required fields